TreeWAS – Variant ID: rs12654812

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N20.0 Calculus of kidney	1.000	0.000	0.000
N20 Calculus of kidney and ureter	0.999	0.001	0.000
N20.1 Calculus of ureter	0.998	0.002	0.000
N20.9 Urinary calculus, unspecified	0.952	0.048	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.596	0.404	0.000
T39.1 4-Aminophenol derivatives	0.595	0.405	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.579	0.421	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.577	0.423	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.550	0.450	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.534	0.466	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.534	0.466	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.510	0.490	0.000
T43.6 Psychostimulants with abuse potential	0.508	0.492	0.000
T39.0 Salicylates	0.507	0.493	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.502	0.498	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.490	0.510	0.000
T43.9 Psychotropic drug, unspecified	0.477	0.523	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.475	0.525	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.464	0.536	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.461	0.539	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.460	0.540	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.458	0.541	0.000
N20.2 Calculus of kidney with calculus of ureter	0.457	0.543	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.455	0.545	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.437	0.563	0.000
N20-N23 Urolithiasis	0.428	0.572	0.000
T39.4 Antirheumatics, not elsewhere classified	0.428	0.572	0.000
T39.2 Pyrazolone derivatives	0.428	0.572	0.000
M79.09 Rheumatism, unspecified (Site unspecified)	0.000	0.577	0.423
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.417	0.583	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.415	0.585	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.413	0.586	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.413	0.586	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.413	0.587	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.412	0.588	0.000
M79.0 Rheumatism, unspecified	0.000	0.588	0.411
M79.00 Rheumatism, unspecified (Multiple sites)	0.000	0.589	0.411
T47.0 Histamine H(2)-receptor antagonists	0.404	0.596	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.398	0.602	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.396	0.604	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.394	0.606	0.000
T47.4 Other laxatives	0.391	0.609	0.000
T47.2 Stimulant laxatives	0.391	0.609	0.000
T36 Poisoning by systemic antibiotics	0.389	0.611	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.383	0.617	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.383	0.617	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.383	0.617	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.383	0.617	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.383	0.617	0.000
T44.0 Anticholinesterase agents	0.383	0.617	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.375	0.625	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.373	0.627	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.371	0.629	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.370	0.630	0.000
T38.1 Thyroid hormones and substitutes	0.367	0.633	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.366	0.634	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.366	0.634	0.000
T47.7 Emetics	0.366	0.634	0.000
T47.6 Antidiarrhoeal drugs	0.366	0.634	0.000
T47.5 Digestants	0.366	0.634	0.000
T47.3 Saline and osmotic laxatives	0.366	0.634	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.351	0.649	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.346	0.654	0.000
M79.08 Rheumatism, unspecified (Other)	0.000	0.668	0.332
T38.9 Other and unspecified hormone antagonists	0.330	0.670	0.000
T38.7 Androgens and anabolic congeners	0.330	0.670	0.000
T38.5 Other oestrogens and progestogens	0.330	0.670	0.000
T38.4 Oral contraceptives	0.330	0.670	0.000
T38.2 Antithyroid drugs	0.330	0.670	0.000
T38.0 Glucocorticoids and synthetic analogues	0.330	0.670	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.326	0.674	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.326	0.674	0.000
T46.7 Peripheral vasodilators	0.326	0.674	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.326	0.674	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.326	0.674	0.000
N23 Unspecified renal colic	0.325	0.675	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.323	0.676	0.000
N22 Calculus of urinary tract in diseases classified elsewhere	0.307	0.693	0.000
M79.06 Rheumatism, unspecified (Lower leg)	0.000	0.699	0.301
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.301	0.699	0.000
T41.5 Therapeutic gases	0.298	0.702	0.000
T41.4 Anaesthetic, unspecified	0.298	0.702	0.000
T41.3 Local anaesthetics	0.298	0.702	0.000
T41.2 Other and unspecified general anaesthetics	0.298	0.702	0.000
T41.1 Intravenous anaesthetics	0.298	0.702	0.000
T41.0 Inhaled anaesthetics	0.298	0.702	0.000
T49.9 Topical agent, unspecified	0.296	0.703	0.000
T49.8 Other topical agents	0.296	0.703	0.000
T49.7 Dental drugs, topically applied	0.296	0.703	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.296	0.703	0.000
T49.5 Ophthalmological drugs and preparations	0.296	0.703	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.296	0.703	0.000
T49.3 Emollients, demulcents and protectants	0.296	0.703	0.000
T49.2 Local astringents and local detergents	0.296	0.703	0.000
T49.1 Antipruritics	0.296	0.703	0.000
M79.07 Rheumatism, unspecified (Ankle and foot)	0.000	0.705	0.295
M79.05 Rheumatism, unspecified (Pelvic region and thigh)	0.000	0.705	0.295
M79.04 Rheumatism, unspecified (Hand)	0.000	0.705	0.295
M79.03 Rheumatism, unspecified (Forearm)	0.000	0.705	0.295
M79.02 Rheumatism, unspecified (Upper arm)	0.000	0.705	0.295
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.294	0.706	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.294	0.706	0.000
T50.8 Diagnostic agents	0.292	0.708	0.000
M79.01 Rheumatism, unspecified (Shoulder region)	0.000	0.708	0.292
N21 Calculus of lower urinary tract	0.290	0.710	0.000
T48.5 Anti-common-cold drugs	0.288	0.711	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.285	0.715	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.283	0.717	0.000
T48.4 Expectorants	0.283	0.717	0.000
T48.3 Antitussives	0.283	0.717	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.283	0.717	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.283	0.717	0.000
T48.0 Oxytocic drugs	0.283	0.717	0.000
T36.9 Systemic antibiotic, unspecified	0.279	0.721	0.000
T36.8 Other systemic antibiotics	0.279	0.721	0.000
T36.7 Antifungal antibiotics, systemically used	0.279	0.721	0.000
T36.6 Rifamycins	0.279	0.721	0.000
T36.5 Aminoglycosides	0.279	0.721	0.000
T36.4 Tetracyclines	0.279	0.721	0.000
T36.3 Macrolides	0.279	0.721	0.000
T36.2 Chloramphenicol group	0.279	0.721	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.279	0.721	0.000
T40.4 Other synthetic narcotics	0.277	0.722	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.271	0.729	0.000
T50.7 Analeptics and opioid receptor antagonists	0.267	0.732	0.000
T50.5 Appetite depressants	0.267	0.732	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.267	0.732	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.267	0.732	0.000
T50.1 Loop [high-ceiling] diuretics	0.267	0.732	0.000
T50.0 Mineralocorticoids and their antagonists	0.267	0.732	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.266	0.734	0.000
T37.5 Antiviral drugs	0.266	0.734	0.000
T37.4 Anthelminthics	0.266	0.734	0.000
T37.3 Other antiprotozoal drugs	0.266	0.734	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.266	0.734	0.000
T37.1 Antimycobacterial drugs	0.266	0.734	0.000
T37.0 Sulphonamides	0.266	0.734	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.266	0.734	0.000
T40.8 Lysergide [LSD]	0.266	0.734	0.000
T40.7 Cannabis (derivatives)	0.266	0.734	0.000
T40.5 Cocaine	0.266	0.734	0.000
T40.3 Methadone	0.266	0.734	0.000
T40.1 Heroin	0.266	0.734	0.000
T40.0 Opium	0.266	0.734	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.255	0.745	0.000
T36.0 Penicillins	0.252	0.747	0.000
T40.2 Other opioids	0.240	0.760	0.000
T40.6 Other and unspecified narcotics	0.235	0.765	0.000
T45.2 Vitamins, not elsewhere classified	0.234	0.766	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.228	0.772	0.000
T50.4 Drugs affecting uric acid metabolism	0.227	0.772	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.221	0.778	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.221	0.779	0.000
N22.8 Calculus of urinary tract in other diseases classified elsewhere	0.220	0.780	0.000
N22.0 Calculus of urinary tract in schistosomiasis [bilharziasis]	0.220	0.780	0.000
N21.0 Calculus in bladder	0.220	0.780	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.216	0.784	0.000
T45.8 Other primarily systemic and haematological agents	0.216	0.784	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.216	0.784	0.000
T45.6 Fibrinolysis-affecting drugs	0.216	0.784	0.000
T45.4 Iron and its compounds	0.216	0.784	0.000
T45.3 Enzymes, not elsewhere classified	0.216	0.784	0.000
T46.1 Calcium-channel blockers	0.212	0.787	0.000
N21.9 Calculus of lower urinary tract, unspecified	0.208	0.792	0.000
N21.8 Other lower urinary tract calculus	0.196	0.804	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.195	0.805	0.000
N21.1 Calculus in urethra	0.191	0.809	0.000
T45.5 Anticoagulants	0.152	0.848	0.000
T45.0 Antiallergic and antiemetic drugs	0.148	0.852	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.147	0.853	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.140	0.860	0.000
T42.3 Barbiturates	0.140	0.860	0.000
T42.2 Succinimides and oxazolidinediones	0.140	0.860	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.139	0.861	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.137	0.863	0.000
T42.1 Iminostilbenes	0.114	0.886	0.000
T42.0 Hydantoin derivatives	0.108	0.892	0.000
T43.2 Other and unspecified antidepressants	0.079	0.921	0.000
C90.0 Multiple myeloma	0.067	0.933	0.000
T42.4 Benzodiazepines	0.066	0.934	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.043	0.957	0.000
C90.2 Plasmacytoma, extramedullary	0.036	0.964	0.000
C90.3 Solitary plasmacytoma	0.034	0.966	0.000
C90.1 Plasma cell leukaemia	0.030	0.970	0.000
L05.0 Pilonidal cyst with abscess	0.000	0.970	0.030
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.029	0.971	0.000
M79.7 Fibromyalgia	0.000	0.975	0.025
M79.79 Fibromyalgia (Site unspecified)	0.000	0.975	0.025
I71 Aortic aneurysm and dissection	0.025	0.975	0.000
I71.2 Thoracic aortic aneurysm, without mention of rupture	0.024	0.976	0.000
M79 Other soft tissue disorders, not elsewhere classified	0.000	0.976	0.024
L05 Pilonidal cyst	0.000	0.977	0.023
L05.9 Pilonidal cyst without abscess	0.000	0.978	0.022
M79.70 Fibromyalgia (Multiple sites)	0.000	0.979	0.021
I71.9 Aortic aneurysm of unspecified site, without mention of rupture	0.021	0.979	0.000
I71.0 Dissection of aorta [any part]	0.020	0.980	0.000
T85.5 Mechanical complication of gastro-intestinal prosthetic devices, implants and grafts	0.000	0.981	0.019
M79.5 Residual foreign body in soft tissue	0.000	0.981	0.018
M79.78 Fibromyalgia (Other)	0.000	0.982	0.018
M79.77 Fibromyalgia (Ankle and foot)	0.000	0.982	0.018
M79.76 Fibromyalgia (Lower leg)	0.000	0.982	0.018
M79.75 Fibromyalgia (Pelvic region and thigh)	0.000	0.982	0.018
M79.74 Fibromyalgia (Hand)	0.000	0.982	0.018
M79.73 Fibromyalgia (Forearm)	0.000	0.982	0.018
M79.72 Fibromyalgia (Upper arm)	0.000	0.982	0.018
M79.71 Fibromyalgia (Shoulder region)	0.000	0.982	0.018
I71.1 Thoracic aortic aneurysm, ruptured	0.018	0.982	0.000
I71.8 Aortic aneurysm of unspecified site, ruptured	0.018	0.982	0.000
I71.5 Thoracoabdominal aortic aneurysm, ruptured	0.018	0.982	0.000
M79.3 Panniculitis, unspecified	0.000	0.982	0.018
I71.6 Thoracoabdominal aortic aneurysm, without mention of rupture	0.017	0.983	0.000
M79.9 Soft tissue disorder, unspecified	0.000	0.984	0.016
M79.4 Hypertrophy of (infrapatellar) fat pad	0.000	0.985	0.015
M79.54 Residual foreign body in soft tissue (Hand)	0.000	0.985	0.015
D32.0 Cerebral meninges	0.015	0.985	0.000
M79.57 Residual foreign body in soft tissue (Ankle and foot)	0.000	0.986	0.014
M79.96 Soft tissue disorder, unspecified (Lower leg)	0.000	0.986	0.014
M79.58 Residual foreign body in soft tissue (Other)	0.000	0.986	0.014
M79.59 Residual foreign body in soft tissue (Site unspecified)	0.000	0.986	0.013
M79.55 Residual foreign body in soft tissue (Pelvic region and thigh)	0.000	0.986	0.013
M79.53 Residual foreign body in soft tissue (Forearm)	0.000	0.986	0.013
M79.52 Residual foreign body in soft tissue (Upper arm)	0.000	0.986	0.013
M79.51 Residual foreign body in soft tissue (Shoulder region)	0.000	0.986	0.013
M79.50 Residual foreign body in soft tissue (Multiple sites)	0.000	0.986	0.013
M79.39 Panniculitis, unspecified (Site unspecified)	0.000	0.987	0.013
M79.38 Panniculitis, unspecified (Other)	0.000	0.987	0.013
M79.37 Panniculitis, unspecified (Ankle and foot)	0.000	0.987	0.013
M79.36 Panniculitis, unspecified (Lower leg)	0.000	0.987	0.013
M79.35 Panniculitis, unspecified (Pelvic region and thigh)	0.000	0.987	0.013
M79.34 Panniculitis, unspecified (Hand)	0.000	0.987	0.013
M79.33 Panniculitis, unspecified (Forearm)	0.000	0.987	0.013
M79.32 Panniculitis, unspecified (Upper arm)	0.000	0.987	0.013
M79.31 Panniculitis, unspecified (Shoulder region)	0.000	0.987	0.013
M79.30 Panniculitis, unspecified (Multiple sites)	0.000	0.987	0.013
I71.3 Abdominal aortic aneurysm, ruptured	0.012	0.987	0.000
M79.93 Soft tissue disorder, unspecified (Forearm)	0.000	0.988	0.012
M79.92 Soft tissue disorder, unspecified (Upper arm)	0.000	0.988	0.012
M79.91 Soft tissue disorder, unspecified (Shoulder region)	0.000	0.988	0.012
M79.90 Soft tissue disorder, unspecified (Multiple sites)	0.000	0.988	0.012
N13.2 Hydronephrosis with renal and ureteral calculous obstruction	0.012	0.988	0.000
M79.95 Soft tissue disorder, unspecified (Pelvic region and thigh)	0.000	0.988	0.011
M79.56 Residual foreign body in soft tissue (Lower leg)	0.000	0.989	0.011
M79.97 Soft tissue disorder, unspecified (Ankle and foot)	0.000	0.989	0.011
M79.49 Hypertrophy of (infrapatellar) fat pad-Site unspec	0.000	0.989	0.011
M79.48 Hypertrophy of (infrapatellar) fat pad (Other)	0.000	0.989	0.011
M79.47 Hypertrophy of (infrapatellar) fat pad (Ankle and foot)	0.000	0.989	0.011
M79.45 Hypertrophy of (infrapatellar) fat pad (Pelvic region and thigh)	0.000	0.989	0.011
M79.44 Hypertrophy of (infrapatellar) fat pad (Hand)	0.000	0.989	0.011
M79.43 Hypertrophy of (infrapatellar) fat pad (Forearm)	0.000	0.989	0.011
M79.42 Hypertrophy of (infrapatellar) fat pad (Upper arm)	0.000	0.989	0.011
M79.41 Hypertrophy of (infrapatellar) fat pad (Shoulder region)	0.000	0.989	0.011
M79.40 Hypertrophy of (infrapatellar) fat pad (Multiple sites)	0.000	0.989	0.011
M79.94 Soft tissue disorder, unspecified (Hand)	0.000	0.990	0.010
M79.99 Soft tissue disorder, unspecified (Site unspecified)	0.000	0.990	0.010
N03 Chronic nephritic syndrome	0.010	0.990	0.000
N00-N08 Glomerular diseases	0.010	0.990	0.000
N04 Nephrotic syndrome	0.010	0.990	0.000
N13.0 Hydronephrosis with ureteropelvic junction obstruction	0.010	0.990	0.000
N05 Unspecified nephritic syndrome	0.010	0.990	0.000
M79.98 Soft tissue disorder, unspecified (Other)	0.000	0.990	0.009
N03.9 Unspecified	0.009	0.991	0.000
N04.9 Unspecified	0.009	0.991	0.000
N05.9 Unspecified	0.009	0.991	0.000
H73.8 Other specified disorders of tympanic membrane	0.000	0.991	0.009
M79.46 Hypertrophy of (infrapatellar) fat pad (Lower leg)	0.000	0.991	0.009
N05.8 Other	0.009	0.991	0.000
N13.8 Other obstructive and reflux uropathy	0.009	0.991	0.000
N13 Obstructive and reflux uropathy	0.009	0.991	0.000
N03.1 Focal and segmental glomerular lesions	0.008	0.992	0.000
D32 Benign neoplasm of meninges	0.008	0.992	0.000
N04.0 Minor glomerular abnormality	0.008	0.992	0.000
N03.8 Other	0.008	0.992	0.000
D32.9 Meninges, unspecified	0.008	0.992	0.000
N04.1 Focal and segmental glomerular lesions	0.008	0.992	0.000
N02 Recurrent and persistent haematuria	0.008	0.992	0.000
N03.5 Diffuse mesangiocapillary glomerulonephritis	0.007	0.992	0.000
N03.7 Diffuse crescentic glomerulonephritis	0.007	0.992	0.000
N03.6 Dense deposit disease	0.007	0.992	0.000
N03.4 Diffuse endocapillary proliferative glomerulonephritis	0.007	0.992	0.000
N03.3 Diffuse mesangial proliferative glomerulonephritis	0.007	0.992	0.000
N03.2 Diffuse membranous glomerulonephritis	0.007	0.992	0.000
N03.0 Minor glomerular abnormality	0.007	0.992	0.000
N07 Hereditary nephropathy, not elsewhere classified	0.007	0.993	0.000
N06 Isolated proteinuria with specified morphological lesion	0.007	0.993	0.000
N01 Rapidly progressive nephritic syndrome	0.007	0.993	0.000
N00 Acute nephritic syndrome	0.007	0.993	0.000
N04.8 Other	0.007	0.993	0.000
N04.7 Diffuse crescentic glomerulonephritis	0.007	0.993	0.000
N04.6 Dense deposit disease	0.007	0.993	0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.007	0.993	0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.007	0.993	0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.007	0.993	0.000
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.007	0.993	0.000
N05.6 Dense deposit disease	0.007	0.993	0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.007	0.993	0.000
N05.1 Focal and segmental glomerular lesions	0.007	0.993	0.000
N05.0 Minor glomerular abnormality	0.007	0.993	0.000
N04.2 Diffuse membranous glomerulonephritis	0.007	0.993	0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.007	0.993	0.000
M79.1 Myalgia	0.000	0.993	0.006
N05.2 Diffuse membranous glomerulonephritis	0.006	0.994	0.000
M79.2 Neuralgia and neuritis, unspecified	0.000	0.994	0.006
N02.1 Focal and segmental glomerular lesions	0.006	0.994	0.000
N02.9 Unspecified	0.006	0.994	0.000
N13.5 Kinking and stricture of ureter without hydronephrosis	0.006	0.994	0.000
N99.4 Postprocedural pelvic peritoneal adhesions	0.006	0.994	0.000
N02.3 Diffuse mesangial proliferative glomerulonephritis	0.006	0.994	0.000
L00-L08 Infections of the skin and subcutaneous tissue	0.000	0.994	0.006
N05.7 Diffuse crescentic glomerulonephritis	0.006	0.994	0.000
Y44.2 Anticoagulants	0.006	0.994	0.000
N13.7 Vesicoureteral-reflux-associated uropathy	0.006	0.994	0.000
Chapter XIV Diseases of the genitourinary system	0.006	0.994	0.000
N02.7 Diffuse crescentic glomerulonephritis	0.006	0.994	0.000
N02.6 Dense deposit disease	0.006	0.994	0.000
N02.5 Diffuse mesangiocapillary glomerulonephritis	0.006	0.994	0.000
N02.4 Diffuse endocapillary proliferative glomerulonephritis	0.006	0.994	0.000
N02.0 Minor glomerular abnormality	0.006	0.994	0.000
N01.9 Unspecified	0.005	0.994	0.000
N01.8 Other	0.005	0.994	0.000
N01.7 Diffuse crescentic glomerulonephritis	0.005	0.994	0.000
N01.6 Dense deposit disease	0.005	0.994	0.000
N01.5 Diffuse mesangiocapillary glomerulonephritis	0.005	0.994	0.000
N01.4 Diffuse endocapillary proliferative glomerulonephritis	0.005	0.994	0.000
N01.3 Diffuse mesangial proliferative glomerulonephritis	0.005	0.994	0.000
N01.2 Diffuse membranous glomerulonephritis	0.005	0.994	0.000
N01.1 Focal and segmental glomerular lesions	0.005	0.994	0.000
N01.0 Minor glomerular abnormality	0.005	0.994	0.000
N06.9 Unspecified	0.005	0.994	0.000
N06.8 Other	0.005	0.994	0.000
N06.7 Diffuse crescentic glomerulonephritis	0.005	0.994	0.000
N06.6 Dense deposit disease	0.005	0.994	0.000
N06.5 Diffuse mesangiocapillary glomerulonephritis	0.005	0.994	0.000
N06.4 Diffuse endocapillary proliferative glomerulonephritis	0.005	0.994	0.000
N06.3 Diffuse mesangial proliferative glomerulonephritis	0.005	0.994	0.000
N06.2 Diffuse membranous glomerulonephritis	0.005	0.994	0.000
N06.1 Focal and segmental glomerular lesions	0.005	0.994	0.000
N06.0 Minor glomerular abnormality	0.005	0.994	0.000
N07.9 Unspecified	0.005	0.994	0.000
N07.8 Other	0.005	0.994	0.000
N07.7 Diffuse crescentic glomerulonephritis	0.005	0.994	0.000
N07.6 Dense deposit disease	0.005	0.994	0.000
N07.5 Diffuse mesangiocapillary glomerulonephritis	0.005	0.994	0.000
N07.4 Diffuse endocapillary proliferative glomerulonephritis	0.005	0.994	0.000
N07.3 Diffuse mesangial proliferative glomerulonephritis	0.005	0.994	0.000
N07.2 Diffuse membranous glomerulonephritis	0.005	0.994	0.000
N07.1 Focal and segmental glomerular lesions	0.005	0.994	0.000
N07.0 Minor glomerular abnormality	0.005	0.994	0.000
N00.8 Other	0.005	0.994	0.000
N00.7 Diffuse crescentic glomerulonephritis	0.005	0.994	0.000
N00.6 Dense deposit disease	0.005	0.994	0.000
N00.5 Diffuse mesangiocapillary glomerulonephritis	0.005	0.994	0.000
N00.4 Diffuse endocapillary proliferative glomerulonephritis	0.005	0.994	0.000
N00.3 Diffuse mesangial proliferative glomerulonephritis	0.005	0.994	0.000
N00.2 Diffuse membranous glomerulonephritis	0.005	0.994	0.000
N00.1 Focal and segmental glomerular lesions	0.005	0.994	0.000
N00.0 Minor glomerular abnormality	0.005	0.994	0.000
N00.9 Unspecified	0.005	0.994	0.000
L60.0 Ingrowing nail	0.000	0.994	0.006
N08 Glomerular disorders in diseases classified elsewhere	0.005	0.994	0.000
H73 Other disorders of tympanic membrane	0.000	0.995	0.005
H53.9 Visual disturbance, unspecified	0.005	0.995	0.000
N81.4 Uterovaginal prolapse, unspecified	0.000	0.995	0.005
L02.3 Cutaneous abscess, furuncle and carbuncle of buttock	0.000	0.995	0.005
L08.8 Other specified local infections of skin and subcutaneous tissue	0.000	0.995	0.005
M79.19 Myalgia (Site unspecified)	0.000	0.995	0.005
N02.2 Diffuse membranous glomerulonephritis	0.005	0.995	0.000
N10-N16 Renal tubulo-interstitial diseases	0.005	0.995	0.000
M79.17 Myalgia (Ankle and foot)	0.000	0.995	0.005
M79.14 Myalgia (Hand)	0.000	0.995	0.005
M79.13 Myalgia (Forearm)	0.000	0.995	0.005
M79.12 Myalgia (Upper arm)	0.000	0.995	0.005
K86.0 Alcohol-induced chronic pancreatitis	0.000	0.995	0.005
N99-N99 Other disorders of the genitourinary system	0.005	0.995	0.000
D32.1 Spinal meninges	0.005	0.995	0.000
M79.24 Neuralgia and neuritis, unspecified (Hand)	0.000	0.995	0.005
M79.23 Neuralgia and neuritis, unspecified (Forearm)	0.000	0.995	0.005
M79.22 Neuralgia and neuritis, unspecified (Upper arm)	0.000	0.995	0.005
M79.21 Neuralgia and neuritis, unspecified (Shoulder region)	0.000	0.995	0.005
M79.16 Myalgia (Lower leg)	0.000	0.995	0.005
L08 Other local infections of skin and subcutaneous tissue	0.000	0.995	0.005
M79.11 Myalgia (Shoulder region)	0.000	0.995	0.004
N13.9 Obstructive and reflux uropathy, unspecified	0.005	0.995	0.000
M79.26 Neuralgia and neuritis, unspecified (Lower leg)	0.000	0.995	0.004
M79.20 Neuralgia and neuritis, unspecified (Multiple sites)	0.000	0.995	0.004
M79.67 Pain in limb (Ankle and foot)	0.000	0.995	0.005
L00 Staphylococcal scalded skin syndrome	0.000	0.995	0.005
K90.9 Intestinal malabsorption, unspecified	0.000	0.995	0.005
N13.4 Hydroureter	0.005	0.995	0.000
L04 Acute lymphadenitis	0.000	0.995	0.004
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified	0.004	0.995	0.000
M79.27 Neuralgia and neuritis, unspecified (Ankle and foot)	0.000	0.996	0.004
H71 Cholesteatoma of middle ear	0.000	0.996	0.004
M81.95 Osteoporosis, unspecified (Pelvic region and thigh)	0.000	0.996	0.004
N99 Postprocedural disorders of genito-urinary system, not elsewhere classified	0.004	0.996	0.000
N02.8 Other	0.004	0.996	0.000
H73.9 Disorder of tympanic membrane, unspecified	0.000	0.996	0.004
M81.90 Osteoporosis, unspecified (Multiple sites)	0.000	0.996	0.004
S42.10 Fracture of scapula (closed)	0.004	0.996	0.000
L01 Impetigo	0.000	0.996	0.004
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.004	0.996	0.000
N08.8 Glomerular disorders in other diseases classified elsewhere	0.004	0.996	0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism	0.004	0.996	0.000
N08.1 Glomerular disorders in neoplastic diseases	0.004	0.996	0.000
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere	0.004	0.996	0.000
N13.6 Pyonephrosis	0.004	0.996	0.000
M79.15 Myalgia (Pelvic region and thigh)	0.000	0.996	0.004
H73.0 Acute myringitis	0.000	0.996	0.004
N99.0 Postprocedural renal failure	0.004	0.996	0.000
N13.3 Other and unspecified hydronephrosis	0.004	0.996	0.000
W19.4 Street and highway	0.004	0.996	0.000
N14 Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions	0.004	0.996	0.000
M79.6 Pain in limb	0.000	0.996	0.004
L04.9 Acute lymphadenitis, unspecified	0.000	0.996	0.004
H47.1 Papilloedema, unspecified	0.004	0.996	0.000
N16 Renal tubulo-interstitial disorders in diseases classified elsewhere	0.004	0.996	0.000
M79.25 Neuralgia and neuritis, unspecified (Pelvic region and thigh)	0.000	0.996	0.004
F17.2 Dependence syndrome	0.000	0.996	0.004
K86.3 Pseudocyst of pancreas	0.000	0.996	0.004
Y44 Agents primarily affecting blood constituents	0.004	0.996	0.000
M81.9 Osteoporosis, unspecified	0.000	0.996	0.004
F33.1 Recurrent depressive disorder, current episode moderate	0.004	0.996	0.000
H53.8 Other visual disturbances	0.004	0.996	0.000
M79.28 Neuralgia and neuritis, unspecified (Other)	0.000	0.996	0.004
M79.18 Myalgia (Other)	0.000	0.996	0.004
Z09.8 Follow-up examination after other treatment for other conditions	0.000	0.996	0.004
L02 Cutaneous abscess, furuncle and carbuncle	0.000	0.996	0.004
L08.1 Erythrasma	0.000	0.996	0.004
L03.8 Cellulitis of other sites	0.000	0.996	0.004
L03 Cellulitis	0.000	0.996	0.004
L02.9 Cutaneous abscess, furuncle and carbuncle, unspecified	0.000	0.996	0.004
N15 Other renal tubulo-interstitial diseases	0.003	0.996	0.000
L08.0 Pyoderma	0.000	0.996	0.003
I97.8 Other postprocedural disorders of circulatory system, not elsewhere classified	0.004	0.996	0.000
L04.2 Acute lymphadenitis of upper limb	0.000	0.996	0.003
H73.1 Chronic myringitis	0.000	0.996	0.003
L04.8 Acute lymphadenitis of other sites	0.000	0.996	0.003
L04.3 Acute lymphadenitis of lower limb	0.000	0.996	0.003
L04.1 Acute lymphadenitis of trunk	0.000	0.996	0.003
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.003	0.996	0.000
N99.5 Malfunction of external stoma of urinary tract	0.003	0.996	0.000
M79.61 Pain in limb (Shoulder region)	0.000	0.997	0.003
N99.1 Postprocedural urethral stricture	0.003	0.997	0.000
M79.68 Pain in limb (Other)	0.000	0.997	0.003
N08.3 Glomerular disorders in diabetes mellitus	0.003	0.997	0.000
M81.93 Osteoporosis, unspecified (Forearm)	0.000	0.997	0.003
L01.1 Impetiginisation of other dermatoses	0.000	0.997	0.003
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
Y44.5 Thrombolytic drugs	0.003	0.997	0.000
N08.5 Glomerular disorders in systemic connective tissue disorders	0.003	0.997	0.000
M81.96 Osteoporosis, unspecified (Lower leg)	0.000	0.997	0.003
L03.0 Cellulitis of finger and toe	0.000	0.997	0.003
N14.1 Nephropathy induced by other drugs, medicaments and biological substances	0.003	0.997	0.000
N14.4 Toxic nephropathy, not elsewhere classified	0.003	0.997	0.000
N14.3 Nephropathy induced by heavy metals	0.003	0.997	0.000
N14.2 Nephropathy induced by unspecified drug, medicament or biological substance	0.003	0.997	0.000
N14.0 Analgesic nephropathy	0.003	0.997	0.000
M79.29 Neuralgia and neuritis, unspecified (Site unspecified)	0.001	0.997	0.003
H65-H75 Diseases of middle ear and mastoid	0.000	0.997	0.003
N16.8 Renal tubulo-interstitial disorders in other diseases classified elsewhere	0.003	0.997	0.000
N16.5 Renal tubulo-interstitial disorders in transplant rejection	0.003	0.997	0.000
N16.4 Renal tubulo-interstitial disorders in systemic connective tissue disorders	0.003	0.997	0.000
N16.3 Renal tubulo-interstitial disorders in metabolic diseases	0.003	0.997	0.000
N16.2 Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism	0.003	0.997	0.000
N16.1 Renal tubulo-interstitial disorders in neoplastic diseases	0.003	0.997	0.000
N16.0 Renal tubulo-interstitial disorders in infectious and parasitic diseases classified elsewhere	0.003	0.997	0.000
M81.98 Osteoporosis, unspecified (Other)	0.000	0.997	0.003
Y44.9 Other and unspecified agents affecting blood constituents	0.003	0.997	0.000
Y44.7 Plasma substitutes	0.003	0.997	0.000
Y44.6 Natural blood and blood products	0.003	0.997	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.003	0.997	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.003	0.997	0.000
N25-N29 Other disorders of kidney and ureter	0.003	0.997	0.000
M81.92 Osteoporosis, unspecified (Upper arm)	0.000	0.997	0.003
M81.91 Osteoporosis, unspecified (Shoulder region)	0.000	0.997	0.003
L03.9 Cellulitis, unspecified	0.000	0.997	0.003
M79.69 Pain in limb (Site unspecified)	0.000	0.997	0.003
M70.22 Olecranon bursitis-Upper arm	0.000	0.997	0.003
N15.1 Renal and perinephric abscess	0.003	0.997	0.000
N26 Unspecified contracted kidney	0.003	0.997	0.000
H53 Visual disturbances	0.003	0.997	0.000
L01.0 Impetigo [any organism] [any site]	0.000	0.997	0.003
L02.8 Cutaneous abscess, furuncle and carbuncle of other sites	0.000	0.997	0.003
M81.94 Osteoporosis, unspecified (Hand)	0.000	0.997	0.003
M79.60 Pain in limb (Multiple sites)	0.000	0.997	0.003
M81.97 Osteoporosis, unspecified (Ankle and foot)	0.000	0.997	0.003
N99.9 Postprocedural disorder of genito-urinary system, unspecified	0.003	0.997	0.000
G25.8 Other specified extrapyramidal and movement disorders	0.003	0.997	0.000
N15.8 Other specified renal tubulo-interstitial diseases	0.003	0.997	0.000
N15.0 Balkan nephropathy	0.003	0.997	0.000
Y83.4 Other reconstructive surgery	0.000	0.997	0.003
H70 Mastoiditis and related conditions	0.000	0.997	0.003
K86 Other diseases of pancreas	0.000	0.997	0.003
M54.96 Dorsalgia, unspecified (Lumbar region)	0.003	0.997	0.000
S32.40 Fracture of acetabulum (closed)	0.003	0.997	0.000
I82.9 Embolism and thrombosis of unspecified vein	0.003	0.997	0.000
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.003	0.997	0.000
F33 Recurrent depressive disorder	0.003	0.997	0.000
Z91.1 Personal history of noncompliance with medical treatment and regimen	0.000	0.997	0.003
L03.2 Cellulitis of face	0.000	0.997	0.003
K86.1 Other chronic pancreatitis	0.000	0.997	0.003

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations